GlassScriptPhysician profile
Thinn Hlaing
NPI 1699976993
$4,636.86
in general payments reported to CMS, 2019-2025
18 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,163 · 2020: $97.20 · 2021: $12.80 · 2022: $1,192 · 2023: $1,687 · 2024: $331 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,201 · Food and Beverage: $971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,201.42 |
| Food and Beverage | $970.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,686.66 | 2023 | Micra |
| Boston Scientific Corporation | $1,334.09 | 2022-2025 | Watchman Flx |
| Medtronic Vascular, INC. | $643.55 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $192.31 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $176.11 | 2019-2020 | |
| Philips North America LLC | $112.78 | 2024-2025 | (Cm9) Amb Mon & Diag Und, Ecc Solutions, Diagnostic Ecg Service |
| Amgen INC. | $82.74 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $73.53 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.16 | 2019-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.71 | 2019-2020 | |
| Heartflow, INC. | $62.46 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $33.16 | 2019-2024 | Farxiga |
| Alnylam Pharmaceuticals INC. | $27.26 | 2024 | Onpattro |
| Abbott Laboratories | $21.98 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $17.05 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $14.99 | 2025 | Barostim Neo System |
| Preventice Services, LLC | $12.80 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thinn Hlaing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.